However, genomic amplification accounted for the upregulation of SOX4 in only a minority of lung carcinomas (9%, 4 out of 42), [8], and the detailed molecular mechanisms underlying SOX4 overexpression in NSCLC remain largely unknown. The gene discussed is SOX4; the disease is non-small cell lung carcinoma.